A pan-cancer analysis has demonstrated that WSB2 is highly expressed in various cancers, and overexpression of WSB2 markedly promotes the proliferation and migration of breast cancer cells, which might depend on p53 signaling pathway (Deng et al., 2025). This evidence concerns the gene TP53 and cancer.